Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Trodusquemine reduces weight, adiposity and improves plasma insulin and leptin in DIO mice

July 5, 2007

Novel adenosine A2B receptor antagonist improves insulin sensitivity in vivo

July 4, 2007

Novel long-acting GLP-1 analogues presented at the ADA meeting

July 4, 2007

Karo Bio delays development of KB-5359 for dyslipidemia

July 4, 2007

New data on treatments for diabetic complications: neuropathy, gastroparesis

July 4, 2007

Studies advance immunomodulating agents for diabetes

July 4, 2007

Studies reveal potential of CS-917 in type 2 diabetes

July 4, 2007

CTA-018 reduces blood levels of parathyroid hormone in phase I trial

July 3, 2007

Liraglutide effective in lowering HbA1c in Japanese type 2 diabetes patients

July 3, 2007

New data on SGLT2 inhibitors sergliflozin, dapagliflozin available

July 3, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Roche secures CE mark for Alzheimer’s blood test
BioWorld
Roche Holding AG secured CE marking for the Elecsys plasma phosphorylated-tau 217 blood test designed to rule in and rule out amyloid pathology, a hallmark of...